US 10287279
Inhibitors of human 12/15-lipoxygenase
granted A61KA61K31/421A61K31/422
Quick answer
US patent 10287279 (Inhibitors of human 12/15-lipoxygenase) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/421, A61K31/422, A61K31/4245, A61K31/426